The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Diabetes Management

Comprehensive management of type 1 and type 2 diabetes through medication, lifestyle, and follow-up.

Long-term, multidimensional management of type 1 and type 2 diabetes covering blood glucose control, medication therapy, nutrition, and complication monitoring.

Indication

  • Initiating treatment planning in patients newly diagnosed with type 1 or type 2 diabetes
  • Patients meeting diagnostic criteria with fasting glucose ≥126 mg/dL, random glucose ≥200 mg/dL, or HbA1c ≥6.5%
  • Early intervention and lifestyle management in prediabetes (impaired fasting glucose or HbA1c 5.7-6.4%)
  • Treatment optimization in patients who do not reach the target HbA1c or experience treatment side effects
  • Frequent hypoglycemia, nocturnal lows, or situations requiring insulin dose adjustment
  • Management of patients diagnosed with gestational diabetes
  • Routine screening and follow-up of diabetic eye, kidney, nerve, and vascular complications

Preparation

  • At the first visit, bring all laboratory results from the past 3 months, current medications, and your glucose log
  • Come fasting in the morning for HbA1c, fasting glucose, lipid profile, creatinine/eGFR, and urine albumin/creatinine ratio tests
  • In patients in whom type 1 diabetes is suspected, preparation is made for C-peptide and autoantibodies (anti-GAD, IA-2A)
  • Bring previous fundoscopy, ECG, and foot examination records
  • Patients using a glucometer, insulin pen, or continuous glucose monitor (CGM) bring their devices

How it's performed

  1. The diabetes type and stage are determined through detailed history, physical examination, and laboratory evaluation
  2. An individualized HbA1c target is set (generally below 7%; in older or comorbid patients the target may be 7.5-8%, while a stricter target is set in pregnancy)
  3. In type 1 diabetes, basal-bolus insulin therapy or insulin pump therapy is planned; carbohydrate counting education is provided
  4. In type 2 diabetes, metformin is the first-line agent, with SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, or insulin added stepwise as needed
  5. An individualized diet, physical activity, and weight management plan is developed with a dietitian (at least 150 minutes of moderate-intensity activity per week)
  6. Education on glucose monitoring, recognizing hypoglycemia, and patient/caregiver training is regularly reinforced

Post-procedure

  • HbA1c is checked every 1-3 months initially, and every 3-6 months in stable patients
  • Annual fundoscopy (retinopathy screening), urine microalbumin (nephropathy), foot examination (neuropathy), and lipid profile are evaluated
  • Cardiovascular risk assessment is performed; blood pressure and LDL targets are set (blood pressure generally <130/80 mmHg)
  • The patient is continuously informed about signs of hypoglycemia, hyperglycemia, foot ulcers, and infection
  • Lifestyle: balanced nutrition, smoking cessation, weight control, and regular exercise are supported

Risks

  • Hypoglycemia (blood glucose <70 mg/dL): tremor, sweating, palpitations; loss of consciousness in severe cases; more frequent with insulin and sulfonylureas
  • Acute complications such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (especially in type 1 diabetes and during infections)
  • Long-term retinopathy (vision loss), nephropathy (kidney failure), neuropathy (sensory loss), and diabetic foot
  • Increased risk of cardiovascular disease, stroke, and peripheral vascular disease
  • Drug-related weight gain (insulin, sulfonylureas), gastrointestinal side effects (metformin, GLP-1), and rarely serious reactions

FAQ

What should my HbA1c target be?

An HbA1c <7% is generally recommended for adults with diabetes, but the target is individualized according to age, disease duration, hypoglycemia risk, and comorbidities. For some patients 6.5% is appropriate, while 7.5-8% may be more suitable for some older or cardiac patients.

Does insulin therapy cause dependence?

Insulin does not cause dependence; it replaces a hormone the body already produces. It is lifelong in type 1 diabetes. In type 2 diabetes it is started when needed, and the dose may sometimes be reduced or even discontinued with lifestyle changes and additional medications.

Can type 2 diabetes 'reverse'?

In early stages, intensive lifestyle changes, weight loss, or bariatric surgery can normalize HbA1c in some patients, allowing medication-free remission. This is generally regarded as 'the disease being well controlled'; lifelong follow-up is still required.

Which foods should I eat on a diabetic diet?

There is no single 'diabetes diet'; a Mediterranean-style diet rich in whole grains, vegetables, legumes, lean protein, and healthy fats is recommended. Sugary beverages, white flour, and processed foods are limited. Building an individual plan with a dietitian is recommended.